ClinicalTrials.gov
public full text
Public Domain
Phase 1 and Phase 2 Clinical Trials of SNUBH-NM-333(18F)
To evaluate pharmacokinetics, safety and efficacy of SNUBH-NM-333(18F), a new diagnostic radiopharmaceutical for PET imaging of amyloid plaques, in Alzheimer's disease patients and healthy volunteers.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families#1139624
- A Study With an Increased Dose Step in Patients That Have Previously Received Placebo or sNN0031.#918970
- Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease#833281
- Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies#871008
- A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327#1101060
Record · ID 872259
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive